Yailiz Calderin Pellot, MD
Physical Medicine & Rehabilitation · Ocala, FLNPI 1245681279
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,782 of the $5,904 with a category attached, or 81.0%. 25 manufacturers reported payments, led by Medtronic at 27.0% of the total. Reporting peaked in 2023 at $2,199 and has fallen 80.1% since, to $437 in 2025. Among physical medicine & rehabilitation clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $34.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$727
- Collegium Pharmaceutical, Inc.$651
- Stimwave Technologies Incorporated$520
- Pfizer$484
- Biohaven Pharmaceuticals, Inc.$369
- plus $2K from 19 others
What the payments were for
- Travel & lodging$1,12219%
- Food & beverage$4,78281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $1,592 |
| AbbVie | 33 | $727 |
| Collegium Pharmaceutical, Inc. | 34 | $651 |
| Stimwave Technologies Incorporated | 4 | $520 |
| Pfizer | 29 | $484 |
| Biohaven Pharmaceuticals, Inc. | 4 | $369 |
| Saluda Medical Americas, Inc. | 2 | $330 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $305 |
| Impel Pharmaceuticals Inc. | 1 | $144 |
| Nevro Corp. | 7 | $124 |
| Curonix LLC | 1 | $119 |
| E.r. Squibb & Sons, L.L.C. | 1 | $115 |
| Lilly USA, LLC | 4 | $77 |
| Amgen | 5 | $75 |
| Abbott | 3 | $63 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Nalu Medical, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $20 |
| Boston Scientific | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$672
- StimQ Receiver Stimulator Kit Channel A US w Receiver$506
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$506
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$506
- Freedom 4A Receiver Kit Channel A US w Receiver$506
- Freedom 8A Receiver Kit Channel A US w Receiver$506
- NURTEC ODT$358
- INTELLIS ADAPTIVESTIM$356
- Evoke$314
- UBRELVY$242
- Trudhesa$144
- QULIPTA$123
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$119
- ZEPOSIA$115
How this compares
$5,904 in reported general payments places this provider in the 90th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 22 | $35,842 |
| BotoxOnabotulinumtoxina | 22 | $31,073 |
| Xtampza ErOxycodone Myristate | 29 | $15,950 |
| BelbucaBuprenorphine Hcl | 12 | $12,302 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 374 | $11,738 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 375 | $9,472 |
| Lidocaine | 39 | $3,973 |
| Pregabalin | 229 | $2,916 |
| Morphine Sulfate ErMorphine Sulfate | 113 | $2,744 |
| Naloxone Hcl | 43 | $2,690 |
| Gabapentin | 232 | $2,519 |
| Tramadol Hcl | 243 | $2,207 |
| Oxycodone Hcl | 103 | $1,602 |
| Tizanidine Hcl | 137 | $1,160 |
| Celecoxib | 87 | $976 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $484 | $35,84222 claims |
| AbbVieBotox | $727 | $31,07322 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $651 | $28,25141 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 618 physical medicine & rehabilitation providers in Florida.
Other physical medicine & rehabilitation in Ocala
- Anuj SharmaOcala$5K
- Anthony GiuffridaFort Lauderdale$271K
- Ryan HafnerSarasota$164K
- Cassandra ListJacksonville$154K
- Marissa McCarthyTampa$94K
- Jose Medina SanchezTampa$30K
- Alan MillerFernandina Beach$26K
- Anish SoniNaples$25K
- Jose de la TorreWesley Chapel$23K
- Kaivalya DeshpandeMiami$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.